55
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Hepatocellular carcinoma ablation and possible immunity in the age of nanosecond pulsed electric fields

Pages 49-55 | Published online: 22 May 2015

References

  • SorrellMFBelongiaEACostaJNational Institutes of Health Consensus Development Conference Statement: management of hepatitis BAnn Intern Med2009150210411019124811
  • TakeharaTTatsumiTSuzukiTHepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responsesGastroenterology200412741189119715480996
  • VickBWeberAUrbanikTKnockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytesHepatology200949262763619127517
  • FriedmanSLMechanisms of hepatic fibrogenesisGastroenterology200813461655166918471545
  • MalhiHGuicciardiMEGoresGJHepatocyte death: a clear and present dangerPhysiol Rev20109031165119420664081
  • HanahanDWeinbergRAThe hallmarks of cancerCell20001001577010647931
  • HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
  • CanbayAFriedmanSGoresGJApoptosis: the nexus of liver injury and fibrosisHepatology200439227327814767974
  • FerlayJShinHRBrayFEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer20101272893291721351269
  • GishRGMarreroJABensonABA multidisciplinary approach to the management of hepatocellular carcinomaGastroenterol Hepatol (N Y)201063 Suppl 7S1S16
  • BoschFXRibesJDíazMClériesRPrimary liver cancer: worldwide incidence and trendsGastroenterology20041275 Suppl 1S5S1615508102
  • SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
  • RahibLSmithBDAizenbergRRosenzweigABFleshmanJMMatrisianLMProjecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United StatesCancer Res201474112913292124840647
  • El-SeragHBHepatocellular carcinoma: recent trends in the United StatesGastroenterology20041275 Suppl 1S27S3415508094
  • FeitelsonMASunBSatiroglu TufanNLLiuJPanJLianZGenetic mechanisms of hepatocarcinogenesisOncogene200221162593260411971194
  • MishraLBankerTMurrayJLiver stem cells and hepatocellular carcinomaHepatology200949131832919111019
  • BraicuCBurzCBerindan-NeagoeIHepatocellular carcinoma: tumorigenesis and prediction markersGastroenterology Res200924191199
  • TangYKitisinKJogunooriWProgenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signalingProc Natl Acad Sci U S A200810572445245018263735
  • MajumdarACurleySAWuXHepatic stem cells and transforming growth factor β in hepatocellular carcinomaNat Rev Gastroenterol Hepatol20129953053822710573
  • LiuMLeeDFChenCTIKKα activation of NOTCH links tumorigenesis via FOXA2 suppressionMol Cell201245217118422196886
  • EndoKUedaTUeyamaJOhtaTTeradaTImmunoreactive E- cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients’ survivalHum Pathol200031555856510836294
  • LimSOGuJMKimMSEpigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoterGastroenterology200813562128214018801366
  • D’AnzeoMFaloppiLScartozziMThe role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatmentMolecules20141956393640624853455
  • BruixJShermanMAmerican Association for the Study of Liver DiseasesManagement of hepatocellular carcinoma: an updateHepatology20115331020102221374666
  • International Consensus Group for Hepatocellular NeoplasiaPathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular NeoplasiaHepatology200949265866419177576
  • HuBTianXSunJMengXEvaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysisInt J Mol Sci20131412235592358024317431
  • RichNSingalAGHepatocellular carcinoma tumour markers: current role and expectationsBest Pract Res Clin Gastroenterol201428584385325260312
  • KamiyamaTYokooHFurukawaJIdentification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysisHepatology20135762314232523322672
  • GonzalezSANovel biomarkers for hepatocellular carcinoma surveillance: has the future arrived?Hepatobiliary Surg Nutr20143641041425568864
  • SchoenbachKHBeebeSJBuescherESIntracellular effect of ultrashort electrical pulsesBioelectromagnetics200122644044811536285
  • BeebeSJApplications for pulse power using nanosecond pulsed electric fields (nsPEFs) in cell biology and cancer treatmentJ Nanomed Biotherapeut Discov20133e123
  • BeebeSJMechanisms of nanosecond pulsed electric field (NsPEF)-induced cell death in cells and tumorsJ Nanomed Res20152100016
  • BeebeSJBioelectrics in basic science and medicine: impact of electric fields on cellular structures and functionsJ Nanomed Nanotechnol2013421000163
  • BeebeSJCell responses without receptors and ligands, using nanosecond pulsed electric fields (nsPEFs)Int J Nanomedicine201383401340424039422
  • VernierPTSunYGundersenMANanoelectropulse-driven membrane perturbation and small molecule permeabilizationBMC Cell Biol200673717052354
  • PakhomovAGBowmanAMIbeyBLAndreFMPakhomovaONSchoenbachKHLipid nanopores can form a stable, ion channel-like conduction pathway in cell membraneBiochem Biophys Res Commun2009385218118619450553
  • StewartDAGowrishankarTRWeaverJCTransport lattice approach to describing electroporation: use of local asymptotic modelIEEE Trans Plasma Sci200432416961708
  • GowrishankarTREsserATVasilkoskiZSmithKCWeaverJCMicrodosimetry for conventional and supra-electroporation in cells with organellesBiochem Biophys Res Commun200634141266127616469297
  • NuccitelliRPliquettUChenXNanosecond pulsed electric fields cause melanomas to self-destructBiochem Biophys Res Commun2006343235136016545779
  • NuccitelliRTranKAthosBNanoelectroablation therapy for murine basal cell carcinomaBiochem Biophys Res Commun2012424344645022771794
  • NuccitelliRTranKLuiKNon-thermal nanoelectroablation of UV-induced murine melanomas stimulates an immune responsePigment Cell Melanoma Res201225561862922686288
  • NuccitelliRHuynhJLuiKNanoelectroablation of human pancreatic carcinoma in a murine xenograft model without recurrenceInt J Cancer201313281933193923001643
  • ChenXKolbJFSwansonRJSchoenbachKHBeebeSJApoptosis initiation and angiogenesis inhibition: melanoma targets for nanosecond pulsed electric fieldsPigment Cell Melanoma Res201023455456320370854
  • ChenXZhuangJKolbJFSchoenbachKHBeebeSJLong term survival of mice with hepatocellular carcinoma after pulse power ablation with nanosecond pulsed electric fieldsTechnol Cancer Res Treat2012111839322181334
  • ChenRSainNMHarlowKTA protective effect after clearance of orthotopic rat hepatocellular carcinoma by nanosecond pulsed electric fieldsEur J Cancer201450152705271325081978
  • NuccitelliRWoodRKreisMFirst-in-human trial of nanoelectroablation therapy for basal cell carcinoma: proof of methodExp Dermatol201423213513724330263
  • BruixJLlovetJMPrognostic prediction and treatment strategy in hepatocellular carcinomaHepatology200235351952411870363
  • ComptonCCByrdDRGarcia-AguilarJAJCC Cancer Staging AtlasNew YorkSpringer-Verlag2012
  • ChildCTurcotteJThe liver and portal hypertensionChildCGSurgery and Portal HypertensionPhiladelphia, PAWB Saunders Co Ltd19645058
  • PughRNMurray-lyonIMDawsonJLPietroniMCWilliamsRTransection of the oesophagus for bleeding oesophageal varicesBr J Surg19736086466494541913
  • LlovetJMBrúCBruixJPrognosis of hepatocellular carcinoma: the BCLC staging classificationSemin Liver Dis199919332933810518312
  • LlovetJMFusterJBruixJBarcelona-Clínic Liver Cancer GroupThe Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinomaLiver Transpl2004102 Suppl 1S115S12014762851
  • Abou-AlfaGKSchwartzLRicciSPhase II study of sorafenib in patients with advanced hepatocellular carcinomaJ Clin Oncol200624264293430016908937
  • VillanuevaAMinguezBFornerAReigMLlovetJMHepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapyAnnu Rev Med20106131732820059340
  • LongGShiresPKPlesciaDBeebeSJKolbJFSchoenbachKHTargeted tissue ablation with nanosecond pulsesIEEE Trans Biomed Eng201158821612167
  • RenWSainNMBeebeSJNanosecond pulsed electric fields (nsPEFs) activate intrinsic caspase-dependent and caspase- independent cell death in Jurkat cellsBiochem Biophys Res Commun2012421480881222554515
  • BeebeSJSainNMRenWInduction of cell death mechanisms and apoptosis by nanosecond pulsed electric fields (nsPEFs)Cells20132113616224709649
  • PakhomovaONGregoryBWSemenovIPakhomovAGTwo modes of cell death caused by exposure to nanosecond pulsed electric fieldPLoS One201387e7027823894630
  • Morotomi-YanoKAkiyamaHYanoKDifferent involvement of extracellular calcium in two modes of cell death induced by nanosecond pulsed electric fieldsArch Biochem Biophys2014555–5564754
  • IbeyBLPakhomovAGGregoryBWSelective cytotoxicity of intense nanosecond-duration electric pulses in mammalian cellsBiochim Biophys Acta20101800111210121920691249
  • GreenDRFergusonTZitvogelLKroemerGImmunogenic and tolerogenic cell deathNat Rev Immunol20099535336319365408
  • KroemerG1GalluzziLKeppOZitvogelLImmunogenic cell death in cancer therapyAnnu Rev Immunol201331517223157435
  • CasaresNPequignotMOTesniereACaspase-dependent immunogenicity of doxorubicin-induced tumor cell deathJ Exp Med2005202121691170116365148
  • BlachèreNEDarnellRBAlbertMLApoptotic cells deliver processed antigen to dendritic cells for cross-presentationPLoS Biol200536e18515839733
  • AlbertMLPearceSFFranciscoLMImmature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytesJ Exp Med19981887135913689763615
  • SauterBAlbertMLFranciscoLLarssonMSomersanSBhardwajNConsequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cellsJ Exp Med2000191342343410662788
  • BasuSBinderRJSutoRAndersonKMSrivastavaPKNecrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathwayInt Immunol200012111539154611058573
  • UhlMKeppOJusforgues-SaklaniHVicencioJMKroemerGAlbertMLAutophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cellsCell Death Differ2009167991100519229247
  • MichaudMMartinsISukkurwalaAQAutophagy-dependent anticancer immune responses induced by chemotherapeutic agents in miceScience201133460621573157722174255
  • ObeidMTesniereAGhiringhelliFCalreticulin exposure dictates the immunogenicity of cancer cell deathNat Med2007131546117187072
  • PanaretakisTKeppOBrockmeierUMechanisms of pre-apoptotic calreticulin exposure in immunogenic cell deathEMBO J200928557859019165151
  • KeppOTesniereAZitvogelLKroemerGThe immunogenicity of tumor cell deathCurr Opin Oncol2009211717619125021
  • GuoZSLiuZBartlettDLOncolytic immunotherapy: dying the right way is a key to eliciting potent antitumor immunityFront Oncol201447424782985
  • SounniNENoelATargeting the tumor microenvironment for cancer therapyClin Chem2013591859323193058
  • DalerbaPChoRWClarkeMFCancer stem cells: models and conceptsAnnu Rev Med20075826728417002552
  • MageeJAPiskounovaEMorrisonSJCancer stem cells: impact, heterogeneity, and uncertaintyCancer Cell201221328329622439924